Cipla, Unitaid ink agreement to reduce ceiling price of HIV drug

10:17 EDT 11 Jun 2018 | PharmaBiz

Cipla and Unitaid have struck a landmark agreement to lower the price of the first combination therapy (containing co─trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in people living with

Original Article: Cipla, Unitaid ink agreement to reduce ceiling price of HIV drug

More From BioPortfolio on "Cipla, Unitaid ink agreement to reduce ceiling price of HIV drug"